awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36257565-B7306E81-ACA4-4B00-9F6A-DD43A5746976
Q36257565-B7306E81-ACA4-4B00-9F6A-DD43A5746976
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36257565-B7306E81-ACA4-4B00-9F6A-DD43A5746976
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus.
P2860
Q36257565-B7306E81-ACA4-4B00-9F6A-DD43A5746976
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36257565-B7306E81-ACA4-4B00-9F6A-DD43A5746976
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a899f4c274bb79fad86bbae9f6cebaee72094979
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.